Target Name: LOC102723553
NCBI ID: G102723553
Other Name(s): C21orf51 | Small integral membrane protein 11A | LOC102723553 variant 3 | Small integral membrane protein 11B, transcript variant 3 | Uncharacterized protein LOC102723553 | SMIM11B | SMIM11 | Small integral membrane protein 11 | Small integral membrane protein 11 (isoform b) | small integral membrane protein 11B | SIM11_HUMAN | FAM165B | uncharacterized LOC102723553

LOC102723553: A Potential Drug Target for Cancer and Other Diseases

LOC102723553 (C21orf51) is a gene that has been identified as a potential drug target and biomarker for various diseases, including cancer. Its unique genetic mutation has been linked to the development of various diseases, including leukemia, and has also been associated with an increased risk of developing certain types of cancer.

The gene, located on chromosome 21, encodes a protein known as the CD28 superfamily type II transmembrane protein. This protein plays a crucial role in cell-to-cell adhesion and has been linked to various diseases, including cancer.

Research has shown that individuals with the genetic mutation have an increased risk of developing certain types of cancer, including leukemia. This is because the mutation has been linked to the development of chromosomal instability, which can lead to the formation of tumors.

In addition to its association with cancer, LOC102723553 has also been linked to a number of other diseases. For example, individuals with the genetic mutation have been shown to have an increased risk of developing autoimmune disorders, such as rheumatoid arthritis and lupus.

Despite these promising findings, more research is needed to fully understand the role of LOC102723553 in disease. Researchers are currently working to develop new treatments for cancer and other diseases associated with the genetic mutation.

In conclusion, LOC102723553 (C21orf51) is a gene that has been identified as a potential drug target and biomarker for various diseases, including cancer. Its unique genetic mutation has been linked to the development of various diseases and its role in disease is still being fully understood. Further research is needed to develop new treatments for cancer and other diseases associated with the genetic mutation.

Protein Name: Small Integral Membrane Protein 11B

More Common Targets

LOC102723560 | LOC102723564 | LOC102723566 | LOC102723568 | LOC102723576 | LOC102723596 | LOC102723639 | LOC102723686 | LOC102723692 | LOC102723724 | LOC102723739 | LOC102723750 | LOC102723769 | LOC102723834 | LOC102723838 | LOC102723850 | LOC102723878 | LOC102723890 | LOC102723906 | LOC102723911 | LOC102723914 | LOC102723944 | LOC102723961 | LOC102724001 | LOC102724012 | LOC102724019 | LOC102724023 | LOC102724034 | LOC102724036 | LOC102724058 | LOC102724080 | LOC102724081 | LOC102724087 | LOC102724104 | LOC102724122 | LOC102724137 | LOC102724142 | LOC102724145 | LOC102724192 | LOC102724229 | LOC102724288 | LOC102724322 | LOC102724355 | LOC102724428 | LOC102724429 | LOC102724434 | LOC102724438 | LOC102724467 | LOC102724497 | LOC102724511 | LOC102724520 | LOC102724527 | LOC102724528 | LOC102724542 | LOC102724551 | LOC102724572 | LOC102724594 | LOC102724632 | LOC102724642 | LOC102724653 | LOC102724682 | LOC102724684 | LOC102724719 | LOC102724748 | LOC102724761 | LOC102724768 | LOC102724778 | LOC102724785 | LOC102724786 | LOC102724790 | LOC102724802 | LOC102724808 | LOC102724849 | LOC102724889 | LOC102724900 | LOC102724929 | LOC102724934 | LOC102724945 | LOC102724948 | LOC102724968 | LOC102724977 | LOC102725019 | LOC102725030 | LOC102725038 | LOC102725065 | LOC102725112 | LOC102725148 | LOC102725159 | LOC102725238 | LOC103171574 | LOC104054148 | LOC105369160 | LOC105369165 | LOC105369166 | LOC105369167 | LOC105369194 | LOC105369197 | LOC105369209 | LOC105369212 | LOC105369213